The Relationship of Insulin-Like Growth Factor 2 to Fetal Growth and Adiposity

Insights

Insulin-like growth factor 2 (IGF-2) is crucial for growth. Research suggests IGF-2 may indicate future infant obesity risk, aiding early intervention for this public health issue.

Area of Science:

  • Pediatric Endocrinology
  • Genetics
  • Metabolic Health

Background:

  • Insulin-like growth factor 2 (IGF-2) is vital for human growth.
  • IGF2 gene overexpression is linked to fetal overgrowth and intrauterine programming of adipose tissue.
  • Childhood obesity is a significant public health concern, often leading to early metabolic diseases.

Purpose of the Study:

  • To review the function of the IGF2 gene.
  • To explore proposed mechanisms linking IGF-2 to adiposity.
  • To examine current literature on IGF-2's relationship with weight and body composition in early life.

Main Methods:

  • Literature review of studies on IGF-2, IGF2 gene, weight, and adiposity.
  • Discussion of proposed biological mechanisms.
  • Synthesis of existing research findings.

Main Results:

  • Conflicting data exists regarding the relationship between IGF-2 and body composition.
  • IGF-2's role in fetal development and adiposity is an area of ongoing research.
  • IGF-2 may be implicated in the intrauterine programming of adipose tissue.

Conclusions:

  • IGF-2 is essential for growth and may influence fetal adiposity.
  • Further research is needed to clarify the role of IGF-2 in infant obesity.
  • IGF-2 may emerge as a predictive marker for childhood obesity risk.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K